Brazil's healthcare sector is rapidly modernizing, creating significant demand for global innovation in areas like AI and digital health. This basket offers exposure to the US and EU-listed pharmaceutical, medical device, and technology titans that supply this growing market.
Published on October 14
Brazil is investing billions in healthcare modernisation, creating massive demand for the advanced medical solutions these global leaders provide. This represents a significant growth opportunity for established healthcare giants.
These companies are at the forefront of medical breakthroughs in AI, digital health, and next-generation treatments. Their cutting-edge solutions are exactly what Brazil needs to transform its healthcare system.
Each company is a established titan in global healthcare with decades of experience and strong market positions. They're the trusted suppliers that healthcare systems worldwide rely on for essential medical technologies.
Brazil's healthcare system is undergoing massive modernisation, creating unprecedented demand for advanced medical solutions. This presents a compelling opportunity to invest in the established global healthcare titans that supply this growing market. These multinational giants are uniquely positioned to benefit from Brazil's multi-billion dollar investment in improving health outcomes.
This collection focuses on large, established healthcare companies from the US and Europe that are leaders in their respective fields. These are the pharmaceutical giants, medical device innovators, and health-tech specialists that provide essential technologies and treatments to Brazil's expanding public and private healthcare sectors.
Each company was selected for its leadership position in global healthcare innovation and strategic positioning to benefit from Brazil's healthcare expansion. These are the foundational companies driving medical progress worldwide, making them essential suppliers to Brazil's modernising healthcare infrastructure.
Market capitalisation breakdown and investor key takeaways for a healthcare leaders basket aimed at the Brazilian market.
JNJ: $459.75B
PFE: $140.60B
ABT: $228.66B
Get the full story on this Basket. Read our detailed article on its risks and potential.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
Home Depot's recent earnings beat highlights consistent consumer spending on smaller household repair and maintenance projects. This ongoing trend presents promising opportunities for various home improvement retailers and building material suppliers.
+3
Here are a few of the assets in this group. Create an account to unlock the full list.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
If you invested across these assets:
In 12 months it might be worth:
+70.83%
On average, analysts expect assets in this group to grow 70.83% over the next year.
10 of 13 assets in this group are rated Buy by professional analysts.
